Learning Objectives: At the conclusion of this presentation, participants will be able to:

: 1) Choose among available options for the management of women with an inherited predisposition towards breast and gynecologic cancer;

 2) Discuss the utility of expanded panel testing in the evaluation of inherited cancer risk; and

 3) Evaluate the role of alternative delivery models for providing cancer risk assessment.



Session date: 
11/01/2019 - 8:00am to 9:00am CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Noah Kauff, MD